TRIAMINIC MULTI-SYMPTOM FEVER OTC
Generic Name and Formulations:
Dextromethorphan HBr 7.5mg, chlorpheniramine maleate 1mg, acetaminophen 160mg; per 5mL; alcohol-free; bubble gum-flavored liq; contains sodium 6mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC MULTI-SYMPTOM FEVER:
Cough, fever, sore throat, allergy symptoms, headache, minor aches and pains.
<4yrs: do not use. 4–6yrs: individualize. 6–12yrs: 10mL every 6 hours as needed; max 4 doses/24 hours.
Children <4yrs old. During or within 14 days of MAOIs. Concomitant other acetaminophen products. For use as a sedative hypnotic.
Liver disease. Glaucoma. Asthma. Lower respiratory disorders. Discontinue if symptoms worsen or persist for ≥3 days.
See Contraindications. Hypertensive crisis with MAOIs. Increased CNS effects with other CNS depressants.
Antitussive + antihistamine + analgesic.
Drowsiness, anticholinergic effects, excitability in children, hepatotoxicity (overdosage).
Endocrinology Advisor Articles
- Effect of HbA1c and Perioperative Glucose on Postoperative Mortality
- GLP-1 Agonists Superior to DPP-4 Inhibitors for Reducing HbA1c, Weight in T2D
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Effect of Growth Hormone Treatment on BMD in Adults With Prader-Willi Syndrome
- Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Pioglitazone May Reduce Cardiovascular, Noncardiovascular Mortality in T2D
- HbA1c Levels Affect Serum Phospholipids, Inflammation inT2D, CVD
- No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia
- Cardiovascular Function May Improve After Cure of Cushing Syndrome
- Primary Prevention Outcomes With Aspirin in T2D and Heart Failure
- Greater Bone Formation With Teriparatide vs Zoledronic Acid in Osteoporosis